Gross Profit: Revenues from operations less the associated costs.
C4 Therapeutics, Inc. (CCCC) had Gross Profit of $11.23M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$11.23M |
|
$-32.17M |
|
-- |
|
|
Gross Profit |
$11.23M |
$45.64M |
|
$-34.41M |
|
$2.25M |
|
$-32.17M |
|
$-32.17M |
|
$-32.17M |
|
$-32.17M |
|
$-32.17M |
|
$-32.17M |
|
$-34.41M |
|
$-34.47M |
|
72.56M |
|
72.56M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$206.86M |
|
$5.13M |
|
$58.62M |
|
$265.49M |
|
$35.95M |
|
-- |
|
$75.14M |
|
$111.08M |
|
$154.41M |
|
$154.41M |
|
$154.41M |
|
74.17M |
|
| Cash Flow Statement Financials | |
$-76.55M |
|
$72.13M |
|
$7.73M |
|
$58.94M |
|
$62.25M |
|
$3.31M |
|
$15.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-306.43% |
|
-306.43% |
|
-- |
|
-286.43% |
|
-286.43% |
|
$-77.14M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
1.72 |
|
52.43 |
|
-20.83% |
|
-20.83% |
|
-12.12% |
|
-20.83% |
|
$2.08 |
|
$-1.06 |
|
$-1.05 |
|